The FDA has placed Kezar Life Sciences’ lupus trial on hold after the biotech flagged four deaths during the phase 2b study.

Zasocitinib at doses of 5 mg or greater vs placebo resulted in greater skin clearance among patients with moderate to severe plaque psoriasis.

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

Delta-9 THC is the main active ingredient (among others) in cannabis that causes alterations in auditory and visual ...

One bottle of Galaxy Treat’s Pluto’s Punch HHC Gummies contains 20 gummies with a total of 300 mg of THC. Each gummy has ...

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / October 7, 2024 / DUBAI, UAE / ACCESSWIRE / October 7, 2024 / Real American ...

A 3-year follow-up of patients with refractory/relapsed indolent non-Hodgkin (NHL) treated with a combination of magrolimab ...

In a SailGP first, a female multiple Olympic gold medallist in sailing has been named driver for the newly formed Brazil ...

The FDA has approved Fasenra® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.

Melum made a 40-yard field goal with 15 seconds left in the game to give the Cardinals a 34-31 win over the Monona Grove ...

A new combination therapy involving belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone showed promising ...